A MYCN-INDEPENDENT MECHANISM MEDIATING SECRETOME REPROGRAMMING AND METASTASIS IN MYCN-AMPLIFIED NEUROBLASTOMA

被引：0
|
作者：
Zhang, Hai-Feng [1 ]
Delaidelli, Alberto [1 ]
Javed, Sumreen [2 ]
Turgu, Busra [1 ]
Yang, Xiaqiu [1 ]
Lizardo, Michael [1 ]
Martinez, Daniel [3 ,4 ]
Maris, John [3 ,4 ]
Bosse, Kristopher [3 ,4 ]
Williams, Karla [2 ]
Sorensen, Poul [1 ]
机构：
[1] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[3] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O122
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [21] Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes
    Sarkar, AK
    Nuchtern, JG
    CANCER RESEARCH, 2000, 60 (07) : 1908 - 1913
  • [22] Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
    Rounbehler, Robert J.
    Li, Weimin
    Hall, Mark A.
    Yang, Chunying
    Fallahi, Mohammad
    Cleveland, John L.
    CANCER RESEARCH, 2009, 69 (02) : 547 - 553
  • [23] EXOSOMES FROM MYCN-AMPLIFIED NEUROBLASTOMA CONTAIN ONCOGENIC MICRORNAS
    Flaegstad, T.
    Haug, B. H.
    Hald, O.
    Utnes, P.
    Lokke, C.
    Einvik, C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S329 - S329
  • [24] Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
    Øyvind H. Hald
    Lotte Olsen
    Gabriel Gallo-Oller
    Lotta Helena Maria Elfman
    Cecilie Løkke
    Per Kogner
    Baldur Sveinbjörnsson
    Trond Flægstad
    John Inge Johnsen
    Christer Einvik
    Oncogene, 2019, 38 : 2800 - 2813
  • [25] Striking Dichotomy in Outcome of MYCN-Amplified Neuroblastoma in the Contemporary Era
    Kushner, Brian H.
    Modak, Shakeel
    Kramer, Kim
    LaQuaglia, Michael P.
    Yataghene, Karima
    Basu, Ellen M.
    Roberts, Stephen S.
    Cheung, Nai-Kong V.
    CANCER, 2014, 120 (13) : 2050 - 2059
  • [26] MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
    Aygun, Nevim
    Altungoz, Oguz
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 345 - 361
  • [27] Exploit the zebrafish to study lymphocyte infiltration in MYCN-amplified neuroblastoma
    Qin, Xiaodan
    Lam, Andrew
    Feng, Hui
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [28] Inhibitors of Ribosome Biogenesis Repress the Growth of MYCN-Amplified Neuroblastoma
    Olsen, L.
    Hald, O.
    Gallo-Oller, G.
    Elfmann, L.
    Lokke, C.
    Kogner, P.
    Sveinbjornsson, B.
    Flaegstad, T.
    Johnsen, J. I.
    Eivik, C.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S337 - S337
  • [29] MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas
    Mohan, Divya
    Nambirajan, Aruna
    Malik, Rafat
    Sharma, Agrima
    Suri, Vaishali
    Kaur, Kavneet
    Doddamani, Ramesh
    Garg, Ajay
    Gupta, Subhash
    Mallick, Supriya
    Sharma, Mehar Chand
    HUMAN CELL, 2024, 37 (03) : 704 - 713
  • [30] The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
    Faisal, Amir
    Vaughan, Lynsey
    Bavetsias, Vassilios
    Sun, Chongbo
    Atrash, Butrus
    Avery, Sian
    Jamin, Yann
    Robinson, Simon P.
    Workman, Paul
    Blagg, Julian
    Raynaud, Florence I.
    Eccles, Suzanne A.
    Chesler, Louis
    Linardopoulos, Spiros
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2115 - 2123
12345